On Thursday 7 March, WHA hosted a panel discussion ahead of International Women’s Day, to explore the unique perspectives of women living with hepatitis. It also celebrated the women that are driving the hepatitis response and supporting other women living with hepatitis.
The aim of this legal research is to compile enacted state laws and regulations regarding reporting requirements for negative HIV and Hepatitis C test results. The research includes all 50 states as well as the District of Columbia and only covers enacted laws and regulations – excluding proposed bills, sub-regulatory guidance, and case law. Reporting requirements for a specific jurisdiction may vary between health care providers and clinical laboratories. Data displayed within this map excludes provisions specific to prenatal/postnatal testing and exposed newborns – infants.
Tens of thousands of new cases of viral hepatitis occur every year in the United States. Viral hepatitis is a serious public health threat that kills thousands of Americans annually and is a leading cause of liver cancer. Hepatitis A and hepatitis B are vaccine-preventable and hepatitis C can be cured. The Viral Hepatitis Surveillance Report — United States, 2022 presents information from the ongoing, systematic collection, analysis, and interpretation of viral hepatitis-related data.
This is an interactive map from HepVu that demonstrates opioid prescription in the United States in 2021.
This is an interactive map from HepVu that demonstrates overdose mortality in the United States in 2021.
This webpage is an online group for qualified liver specialists who are knowledgeable about chronic hepatitis B to be listed in the Hepatitis B Foundation's Physician Directory.
The webinar walks through the HepVu 2022 Viral Hepatitis Surveillance Status Report.
This toolkit includes sample social media messages and infographics to amplify and highlight the key findings from the 2022 Viral Hepatitis Surveillance Status Report.
This infographic is an assessment of the status of viral hepatitis surveillance practices across U.S. jurisdictions in 2022.
This publication discusses how people who engage in drug use or high-risk behaviors associated with drug use put themselves at risk for contracting or transmitting viral infections such as HIV/AIDS or hepatitis.
